Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 4, 2011
Patent Application Number
10537719
Date Filed
December 15, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
